SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024

Reuters

07-15

<a href="https://laohu8.com/S/SNWV">SANUWAVE Health</a> Inc. Reports Record <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue, Up 41-42% from Q2 2024

SANUWAVE Health Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the "elephant hunter," has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its performance and future plans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9493257-en) on July 14, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2551135797"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551135797\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2551135797?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-15 04:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551135797","market":"nz","top_or_hot":-1,"title":"SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SNWV\">SANUWAVE Health</a> Inc. Reports Record <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue, Up 41-42% from Q2 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SNWVD\">SANUWAVE Health</a> Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the \"elephant hunter,\" has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its performance and future plans.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9493257-en) on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-15 04:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SNWV\">SANUWAVE Health</a> Inc. Reports Record <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue, Up 41-42% from Q2 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SNWVD\">SANUWAVE Health</a> Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the \"elephant hunter,\" has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its performance and future plans.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9493257-en) on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NDAQ","symbol_name":"纳斯达克OMX交易所","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL3yDwM5:1","article_id":"2551135797","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551135797","pubTimestamp":1752525030,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"SANUWAVE Health Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the \"elephant hunter,\" has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its perfo","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"NDAQ":"纳斯达克OMX交易所","SNWV":"SANUWAVE Health, Inc."},"translate_title":"SANUWAVE Health Inc.报告2025年第二季度收入创历史新高，较2024年第二季度增长41-42%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"SNWV":0.9},"content_text":"SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024\n    \n\nSANUWAVE Health Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the \"elephant hunter,\" has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its performance and future plans.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9493257-en) on July 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}